
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.950 | 1.020 | 0.070 |
Shares | 99.060 | 99.060 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.690 | 19.721 |
Price to Book | 3.789 | 3.900 |
Price to Sales | 1.684 | 2.233 |
Price to Cash Flow | 13.063 | 14.997 |
Dividend Yield | 1.673 | 1.495 |
5 Years Earnings Growth | 7.687 | 9.862 |
Number of long holdings: 51
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.05 | 625.65 | -2.37% | |
AstraZeneca | GB0009895292 | 6.44 | 10,922.0 | -0.26% | |
Roche Holding Participation | CH0012032048 | 6.36 | 246.40 | -1.08% | |
Novo Nordisk B | DK0062498333 | 6.17 | 323.1 | +4.60% | |
J&J | US4781601046 | 6.02 | 173.33 | +1.05% | |
Lonza Group | CH0013841017 | 3.78 | 544.60 | -0.95% | |
UnitedHealth | US91324P1021 | 3.48 | 250.89 | +2.54% | |
Sanofi | FR0000120578 | 3.25 | 80.93 | +0.11% | |
DexCom | US2521311074 | 3.24 | 78.86 | +3.22% | |
Thermo Fisher Scientific | US8835561023 | 3.02 | 460.72 | +1.32% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNB Global indeks NOK | 124.08B | 0.21 | 18.14 | 13.09 | ||
DNB Teknologi NOK | 84.83B | 5.85 | 28.33 | 21.58 | ||
Pensjonsprofil 80 | 55.44B | 7.31 | 11.27 | 8.80 | ||
DNB Global IV | 44.99B | 0.49 | 18.99 | 13.64 | ||
Pensjonsprofil 50 | 29.41B | 6.18 | 8.73 | 6.66 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review